A low expression of miR-124 in lung cancer cells shows a significant increment in glucose consumption and ATP production [18] by upregulating GLUT1 and HK2 expressions, both of which are key enzymes in the rate-limiting step of the glycolytic pathway. The gene discussed is SLC2A1; the disease is lung carcinoma.